Duration of Use of Highly Effective Reversible Contraception
NCT02414919 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13880
Last updated 2017-03-16
Summary
To assess the proportion of women who use HERC for ≥2 years of duration
Conditions
- Pregnancy
Interventions
- DRUG
-
Mirena (Levonorgestrel IUS, BAY86-5028)
Levonorgestrel-releasing intrauterine device 20 mcg/day
- DRUG
-
ParaGard
Copper T380A
- DRUG
-
Implanon/Nexplanon
Etonorgestrel contraceptive implant
Sponsors & Collaborators
- collaborator OTHER
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Eligibility
- Min Age
- 15 Years
- Max Age
- 44 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-01
- Primary Completion
- 2016-03-28
- Completion
- 2016-03-28
Countries
- United States
Study Locations
More Related Trials
-
Mirena Extension Trial
NCT02985541 ·Status: COMPLETED ·Phase: PHASE3
-
Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
NCT00393198 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Efficacy, Safety, and Tolerability of LevoCept
NCT04457076 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
NCT00995150 ·Status: TERMINATED ·Phase: PHASE3
-
Immediate Versus Delayed Initiation of Intrauterine System
NCT03708809 ·Status: WITHDRAWN ·Phase: NA
-
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
NCT00360490 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
Mirena Post-marketing Surveillance in Japan
NCT01414140 ·Status: COMPLETED
-
Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)
NCT00185380 ·Status: COMPLETED ·Phase: PHASE2
-
European Active Surveillance Study of LCS12
NCT02146950 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception
NCT01963962 ·Status: COMPLETED
-
Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception
NCT02446821 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding
NCT01695902 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
NCT00253019 ·Status: COMPLETED
-
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
NCT04143659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS
NCT03633799 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Birth Control Patch Study
NCT00984789 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.
NCT06188026 ·Status: COMPLETED ·Phase: PHASE1
-
Hormonal Management of Heavy Menstrual Bleeding in Adolescents
NCT06740929 ·Status: RECRUITING
-
A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia
NCT01074892 ·Status: COMPLETED ·Phase: PHASE4
-
Immediate Postpartum Insertion of Contraceptive Intrauterine Devices
NCT03657602 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Stopping Heavy Periods Project
NCT02002260 ·Status: UNKNOWN ·Phase: NA
-
Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone Acetate
NCT05294341 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Acting Progestin Contraception and the Vaginal Microbiome
NCT02740998 ·Status: COMPLETED
-
Mirena or Conventional Medical Treatment for Menorrhagia
NCT00864136 ·Status: COMPLETED